Table 1

List of bioassays used for characterization in the initial screen and result summary

Therapeutic Field
Bioassays
Phenotype

Cardiovascular, renal and bladder function
Bladder function (F)
NS

Blood pressure/heart rate (M)
↑(BP)*

Urine chemistry panel (F)
NS

CNS and Behavior
Irwin test (M,F)
↓***

Cross-therapeutic assays
Automated blood chemistry panel (M)
NS

Body weight measurements (M,F)
NS

Corticosterone (M)
↑*

Immunology and Inflammation
DTH (M)
NS

FACS analysis (M)
↓*

LPS challenge (M)
NS

Monocyte infiltration (F)
↑*

Pulmonary inflammation (F)
NS

Wound healing (F)
NS

Metabolism and Body Composition
DEXA (F)
↓*

Excised bone DEXA (F)
↓**

Food intake (M,F)
NS

Food intake on HFD (M)
↑***

Leptin (M,F)
↓**

Metabolic response to HFD (M)
↑**

Physical response to HFD (M)
↓***

Selected muscle weight (F)
↓**

Pain
Formalin pain assay (M)
NS

Hot-plate assay (F)
NS

Sexual health
Histopathology of reproductive system (M)
NS

Induced erection test (M)
↓*

Male contact sexual behavior (M)
↓***

Male fertility (M)
↓***

Testosterone (M)
NS

The highest levels of significance among all measures measured in the assay are shown by asterisks: * P < 0.05, ** 0.001 < P < 0.01, *** P < 0.001 and arrows indicate measurements in the TG line increased or decreased from WT. No significant difference between genotypes (NS), males (M), females (F), delayed-type hypersensitivity (DTH), fluorescence-activated cell sorting (FACS), lipopolysaccharide (LPS), Dual energy X-ray analysis (DEXA) high fat diet (HFD).

Hayward et al. BMC Physiology 2007 7:13   doi:10.1186/1472-6793-7-13